Quick Answer
ELITE PHARMACEUTICALS INC /NV/ reported Diluted EPS of $0.00 per share for fiscal year 2025.
ELITE PHARMACEUTICALS INC /NV/ Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.00 | -100.0% |
| 2024 | $0.02 | — |
| 2023 | $0.00 | -100.0% |
| 2022 | $0.01 | — |
| 2021 | $0.00 | — |
| 2020 | $0.00 | +100.0% |
| 2019 | -$0.01 | +0.0% |
| 2018 | -$0.01 | +0.0% |
| 2017 | -$0.01 | +0.0% |
| 2016 | -$0.01 | +50.0% |
| 2015 | -$0.02 | +90.5% |
| 2014 | -$0.21 | — |
| 2013 | $0.00 | +100.0% |
| 2012 | -$0.06 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.01 | +200.0% | +0.0% |
| September 30, 2025 | $0.01 | +200.0% | +200.0% |
| June 30, 2025 | -$0.01 | — | +0.0% |
| December 31, 2024 | -$0.01 | — | +0.0% |
| September 30, 2024 | -$0.01 | -200.0% | — |
| June 30, 2024 | $0.00 | — | — |
| December 31, 2023 | $0.00 | — | -100.0% |
| September 30, 2023 | $0.01 | — | — |
- ELITE PHARMACEUTICALS INC /NV/ showed a decrease of -100.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2012–2025 period, ELITE PHARMACEUTICALS INC /NV/’s diluted eps has grown by 100.0% (from $0.06 per share (loss) to $0.00 per share).
- The most recent figure is from ELITE PHARMACEUTICALS INC /NV/’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: